Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00793455 · ClinicalTrials.gov registry record · NA
Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 628
- Enrollment target
NCT00793455: Completed NA study, sponsored by Northwestern University.
NCT00793455 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 628 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00793455, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 628 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether patient outreach is effective at increasing compliance with preventive screenings ordered by their physician. We hypothesize that educational outreach may increase completion rates.
Primary Outcome
We reviewed electronic health records of participants 3 months post randomization to ascertain outcome. We looked for one or both of the following (1) note in free text MD note documenting receipt of one form of colorectal cancer (CRC) screening during study period (2)lab results from fecal occult blood test, sigmoidoscopy, or colonoscopy. Participants were categorized as completing CRC screening if there was a lab result or physician note located in chart during study period. If no note or lab
Interventions
- BEHAVIORAL Educational outreach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 628 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-11 |
| Phase | NA |
What the finished NCT00793455 record still lists
NCT00793455 is an interventional study that assigns participants to a tested intervention. The registered 628 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which Educational outreach is the first listed.
NCT00793455 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00793455 about?
NCT00793455 is a clinical study titled "Outreach for Patients With Uncompleted Colorectal Cancer Screening Orders". The purpose of this study is to evaluate whether patient outreach is effective at increasing compliance with preventive screenings ordered by their physician. We hypothesize that educational outreach may increase completion rates.
What is the current status of trial NCT00793455?
This trial is currently completed. It is a NA study. The enrollment target is 628 participants. The study started on 2008-10. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00793455?
The interventions under investigation include: Educational outreach (BEHAVIORAL).
Who is sponsoring clinical trial NCT00793455?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00793455's enrollment target sits among peer trials
628 160th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia